Kenichi Inoue Selected Research

Kenichi Inoue Research Topics

Disease

80	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2002
33	Neoplasms (Cancer) 09/2021 - 01/2006
11	Neutropenia 09/2021 - 01/2006
9	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2007
7	Diarrhea 09/2021 - 01/2013
7	Nausea 02/2019 - 02/2009
6	Disease Progression 11/2021 - 01/2010
6	Triple Negative Breast Neoplasms 01/2020 - 03/2011
6	Vomiting 02/2019 - 02/2009
5	Leukopenia 09/2021 - 01/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2020 - 08/2013
3	Pain (Aches) 01/2018 - 07/2011
3	Fatigue 09/2017 - 02/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2016
2	Hyperglycemia 01/2019 - 09/2012
2	Alopecia (Baldness) 06/2018 - 12/2015
2	Febrile Neutropenia 08/2017 - 10/2006
2	Constipation 01/2013 - 02/2009
2	Body Weight (Weight, Body) 09/2012 - 10/2009
2	Margins of Excision 03/2010 - 08/2009
2	Ductal Carcinoma 01/2007 - 07/2003
1	Injection Site Reaction 01/2022
1	Vascular Remodeling 07/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Stomatitis 12/2019
1	Residual Neoplasm 01/2019
1	Exanthema (Rash) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Tremor (Tremors) 01/2019

Drug/Important Bio-Agent (IBA)

19	Hormones (Hormone)IBA 11/2021 - 01/2007
18	Trastuzumab (Herceptin)FDA Link 08/2021 - 01/2006
16	Estrogen ReceptorsIBA 09/2021 - 09/2006
16	ErbB Receptors (EGF Receptor)IBA 09/2021 - 01/2010
13	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 08/2003
9	AnthracyclinesIBA 01/2020 - 02/2009
9	Docetaxel (Taxotere)FDA Link 05/2017 - 01/2006
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2017 - 02/2009
8	Fulvestrant (Faslodex)FDA Link 11/2021 - 08/2017
8	human ERBB2 proteinIBA 10/2020 - 04/2011
7	palbociclibIBA 03/2021 - 08/2017
6	eribulin FDA Link 07/2021 - 01/2016
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2007
5	abemaciclibIBA 11/2021 - 09/2017
5	neratinibIBA 01/2021 - 12/2016
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2013
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2011
5	taxaneIBA 03/2017 - 03/2011
4	Lapatinib (GW572016)FDA Link 08/2021 - 05/2013
4	Palonosetron (Aloxi)FDA Link 02/2019 - 02/2009
4	Epirubicin (Ellence)FDA LinkGeneric 01/2016 - 05/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 01/2010
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2009
3	exemestane (Aromasin)FDA Link 09/2021 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
3	pertuzumabIBA 02/2020 - 01/2019
3	Taxoids (Taxanes)IBA 01/2020 - 03/2011
3	130-nm albumin-bound paclitaxelIBA 12/2019 - 08/2013
3	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2017
3	Aromatase InhibitorsIBA 01/2018 - 04/2011
3	Fluorouracil (Carac)FDA LinkGeneric 09/2015 - 05/2013
3	Tamoxifen FDA LinkGeneric 12/2014 - 04/2011
2	Neurokinin-1 Receptor AntagonistsIBA 01/2022 - 02/2019
2	atezolizumabIBA 01/2020 - 12/2019
2	Amino Acids FDA Link 01/2020 - 02/2016
2	Letrozole (Femara)FDA LinkGeneric 01/2020 - 03/2018
2	B7-H1 AntigenIBA 12/2019 - 11/2019
2	Messenger RNA (mRNA)IBA 06/2019 - 08/2013
2	Cyclin-Dependent Kinase 4IBA 01/2019 - 09/2017
2	Bevacizumab (Avastin)FDA Link 06/2018 - 01/2017
2	Granisetron (Kytril)FDA LinkGeneric 01/2016 - 02/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 02/2009
2	Hemoglobins (Hemoglobin)IBA 12/2015 - 10/2006
2	orantinib (SU6668)IBA 01/2014 - 08/2013
2	Oxycodone (Oxycontin)FDA LinkGeneric 08/2013 - 07/2011
2	SandIBA 10/2009 - 05/2008
2	Coloring Agents (Dyes)IBA 01/2006 - 01/2006
1	AntiemeticsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 09/2021
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 02/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	titanium silicide (TS-1)IBA 01/2020
1	5'-palmitoyl cytarabine (PLAC)IBA 12/2019
1	Biological ProductsIBA 03/2019
1	netupitantIBA 02/2019
1	Cyclin D1IBA 01/2019
1	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 01/2019
1	AlpelisibIBA 01/2019

Therapy/Procedure

40	Therapeutics 11/2021 - 01/2002
21	Drug Therapy (Chemotherapy) 01/2022 - 10/2006
11	Neoadjuvant Therapy 01/2020 - 01/2007
7	Adjuvant Chemotherapy 01/2020 - 07/2003
4	Radiotherapy 05/2015 - 09/2006
4	Lymph Node Excision (Lymph Node Dissection) 01/2010 - 01/2007
3	Segmental Mastectomy (Lumpectomy) 06/2013 - 08/2009
2	Duration of Therapy 09/2021 - 01/2019
2	Mastectomy (Mammectomy) 05/2015 - 04/2011
1	Lasers (Laser) 06/2019
1	Drug Tapering 01/2019